Paloma Partners’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Paloma Partners's AGN Position: Q2 2020 in Review
Paloma Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 59,966 shares — an estimated $10.6M sold.
Paloma Partners first reported a position in AGN in Q3 2013 and held it in 21 quarters. The position peaked at $30.1M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Paloma Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Paloma Partners sold 59,966 Allergan plc shares in Q2 2020, an estimated $10.6M.
- Paloma Partners first reported a position in Allergan plc in Q3 2013 and held it in 21 quarters.
- Paloma Partners's Allergan plc position peaked at $30.1M in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Paloma Partners's 13F filing for Q2 2020, filed 14 Aug 2020.